Epstein File EFTA00506070: Barr, Threatening and Controlled (DS9)

Epstein Index›Documents›EFTA00506070

⚡IMPACT LEVEL 3 — NOTEWORTHY

Epstein File EFTA00506070: Barr, Threatening and Controlled (DS9)

General DocumentDate unavailableEFTA005060701 keyword hits

1

views

0

shares

0

reactions

3

persons

2

keywords

6

excerpts

This document is a pharmaceutical research summary concerning EPB-348, a treatment for Epstein-Barr Virus (EBV) and related herpesviruses. The document describes a double-blinded, placebo-controlled Phase 2 clinical study with a 2g BID treatment regimen and includes information about the drug's efficacy compared to existing antivirals. The document does not contain information related to Jeffrey Epstein or the criminal case.

👤 Named in This Document

Jeffrey Epstein Bill Barr William Barr

🔑 Evidence Keywords

threatening controlled

📋 Key Excerpts6

PersonKeyword

Excerpt 1

impacted by herpesviruses (EBV, HSV-1) Background EBV appears to play an etiological and/or exasperating role in a number of rare, but serious and life-**threatening**

Excerpt 2

fold more potent in vitro than acyclovir, penciclovir, or foscarnet Phase 2 study of EPB-348 for EBV infectious mononucleosis Double-blinded, placebo-**controlled**

Excerpt 3

& Milestones Screening/ 21-day 35-day Randomization treatment follow-up EPB-348 Treatment 2g BID Regimen Study Design Placebo Double-blinded, placebo **controlled**